Global Automated Endoscope Reprocessor (AER) Market Outlook, 2030

Global Automated Endoscope Reprocessor (AER) Market Introduction The global Automated Endoscope Reprocessor (AER) market is a critical pillar of infection prevention in modern healthcare, ensuring the safe and efficient sterilization of endoscopes used in millions of diagnostic and therapeutic procedures annually. As endoscopes are highly complex, reusable medical devices prone to contamination, AERs have become indispensable in hospitals, ambulatory surgical centers, and specialty clinics to eliminate pathogens and prevent healthcare-associated infections (HAIs). The market is experiencing robust growth, driven by the rising volume of endoscopic procedures—such as colonoscopies, bronchoscopies, and ERCPs—along with heightened awareness of cross-contamination risks following high-profile outbreaks linked to improperly reprocessed scopes. Regulatory bodies like the FDA and EMA have tightened guidelines, mandating stringent validation protocols for AERs, while technological advancements, including touchscreen interfaces, automated tracking, and dual-cycle disinfection, are enhancing efficiency and compliance. The COVID-19 pandemic further underscored the need for reliable reprocessing, accelerating adoption in emerging markets. Trade programs, such as the FDA’s 510(k) clearances and the EU’s Medical Device Regulation (MDR), ensure device efficacy and safety, fostering trust among healthcare providers. With endoscopy demand surging due to aging populations and the rise of minimally invasive techniques, the AER market is poised for sustained expansion, playing a silent but vital role in safeguarding patient outcomes worldwide.

According to the research report " Global Automated Endoscope Reprocessor (AER) Market Overview, 2030," published by Bonafide Research, the Global Automated Endoscope Reprocessor (AER) Market is anticipated to grow at more than 6.2% CAGR from 2025 to 2030. The Automated Endoscope Reprocessor (AER) market is evolving rapidly, fueled by a convergence of technological innovation and regulatory urgency. The shift toward high-level disinfection (HLD) and sterilization is paramount, with hospitals prioritizing AERs capable of eliminating resilient pathogens like C. difficile and CRE. Single-use endoscopes are emerging as competitors, yet reprocessing remains cost-effective for most facilities, sustaining AER demand. Integration of IoT and AI is transforming reprocessing—smart AERs now track cycle data, flag maintenance needs, and sync with hospital EHRs to ensure compliance with Joint Commission standards. The outbreak-driven mindset post-COVID has heightened investments in infection control, while gastrointestinal and pulmonary procedure volumes (e.g., for cancer screening) are skyrocketing, further propelling market growth. Trade programs like FDA’s enforcement of duodenoscope reprocessing guidelines and ISO 15883 certifications are raising the bar for device validation. Meanwhile, ambulatory surgical centers (ASCs) and specialty clinics are adopting compact, rapid-cycle AERs to streamline workflows. Sustainability is also in focus, with water- and energy-efficient models gaining traction.

The Reprocessing Arsenal Step into the world of AERs, and you’ll find a diverse lineup of machines tailored to every endoscope’s quirks. Single-Basin AERs are the workhorses of busy GI suites, offering rapid turnover for high-volume colonoscopies, while Double-Basin Systems separate washing and disinfection phases for meticulous bronchoscope reprocessing. Tabletop Models fit snugly in clinics and dental offices, perfect for ureteroscopes or ENT scopes, whereas Floor-Standing Behemoths dominate hospital sterile processing departments (SPDs), handling 20+ scopes daily with robotic precision. UV-Enhanced AERs zap residual biofilms with light, and Plasma Sterilizer Combos cater to critical devices like duodenoscopes. Emerging "Dry" AERs eliminate water use—ideal for water-scarce regions—and Portable Units serve mobile endoscopy vans. Whether it’s a frugal outpatient center or a cutting-edge university hospital, the AER market delivers a tailored sterilization guardian for every scope and setting.

A Global Sterilization Mosaic The AER market’s geography mirrors healthcare disparities and innovation hubs. North America (40% market share) leads with ironclad FDA mandates and ASCs investing in compact AERs, while Europe leans on EU MDR compliance and green tech—Germany’s washer-disinfectors set global benchmarks. Asia-Pacific is the growth rocket, with Japan’s aging population driving endoscopy demand and India’s private hospitals modernizing reprocessing infrastructure. China’s domestic AER makers are gaining ground, undercutting imports with budget models. Latin America shows promise, as Brazil’s SUS system expands access to endoscopy, but economic volatility slows adoption. The Middle East’s med-tech boom (UAE, Saudi Arabia) favors premium AERs with Arabic interfaces, while Africa relies on donor-funded units in urban centers. From Swiss-engineered precision to Indian frugal innovation, each region’s AER adoption tells a story of healthcare priorities—where reprocessing isn’t just protocol, but a cultural commitment to patient safety.

The automated endoscope reprocessor market is segmented on the basis of product, and region. The automated endoscope reprocessor market is segmented as below:



By product:
- single chamber AER
- multi chamber AER

By region:
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)

The report also provides analysis of the key companies of the industry and their detailed company profiles including Advanced Sterilization Products Services Inc (Fortive Corporation), Belimed AG, Cantel Medical Corporation (BHT Hygienetechnik Holding GmbH), Custom Ultrasonics, Inc., Ecolab, Inc., ENDO-TECHNIK W. Griesat GmbH, Getinge AB, Huons Medicare Co., Ltd., Olympus Corporation, Shinva Medical Instrument Co., Ltd., Steelco SpA, STERIS plc (Cantel Medical Corp.), Wassenburg Medical B.V. (Hoya Corporation), among others.

Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global automated endoscope reprocessor market.
- To classify and forecast the global automated endoscope reprocessor market based on product, and region.
- To identify drivers and challenges for the global automated endoscope reprocessor market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global automated endoscope reprocessor market.
- To identify and analyze the profile of leading players operating in the global automated endoscope reprocessor market.